Page last updated: 2024-09-05

bd 1047 and u-50488

bd 1047 has been researched along with u-50488 in 1 studies

Compound Research Comparison

Studies
(bd 1047)
Trials
(bd 1047)
Recent Studies (post-2010)
(bd 1047)
Studies
(u-50488)
Trials
(u-50488)
Recent Studies (post-2010) (u-50488)
1180541,6643209

Protein Interaction Comparison

ProteinTaxonomybd 1047 (IC50)u-50488 (IC50)
Delta-type opioid receptorRattus norvegicus (Norway rat)2.15
Kappa-type opioid receptorMus musculus (house mouse)0.0027
Mu-type opioid receptorRattus norvegicus (Norway rat)2.15
Kappa-type opioid receptorRattus norvegicus (Norway rat)0.7171
Kappa-type opioid receptorCavia porcellus (domestic guinea pig)0.0958
Kappa-type opioid receptorHomo sapiens (human)0.0537

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Aricò, G; Marrazzo, A; Parenti, C; Prezzavento, O; Ronsisvalle, G; Ronsisvalle, S; Scoto, GM; Vittorio, F1

Other Studies

1 other study(ies) available for bd 1047 and u-50488

ArticleYear
A new sigma ligand, (+/-)-PPCC, antagonizes kappa opioid receptor-mediated antinociceptive effect.
    Life sciences, 2008, Mar-12, Volume: 82, Issue:11-12

    Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Analgesics; Animals; Cyclopropanes; Dose-Response Relationship, Drug; Ethylenediamines; Ligands; Male; Molecular Structure; Pain Measurement; Pentazocine; Piperidines; Rats; Rats, Sprague-Dawley; Receptors, Opioid, kappa; Receptors, sigma

2008